In IHC with anti-PAR1-QDs using human breast cancer tissue samples with detailed clinical information, the number of QDs in a cancer cell was strongly correlated with the relapse-free survival time of HER2-negative breast cancer patients with metastasis within 3 years after surgery. Here, ERBB2 is linked to breast carcinoma.